MU
Mirova US’s Thermo Fisher Scientific TMO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $279M | Sell |
687,066
-101,873
| -13% | -$41.3M | 2.88% | 15 |
|
2025
Q1 | $393M | Buy |
788,939
+26,414
| +3% | +$13.1M | 4.66% | 8 |
|
2024
Q4 | $397M | Sell |
762,525
-23,283
| -3% | -$12.1M | 4.76% | 7 |
|
2024
Q3 | $486M | Buy |
785,808
+4,800
| +0.6% | +$2.97M | 5.58% | 6 |
|
2024
Q2 | $432M | Buy |
781,008
+16,189
| +2% | +$8.95M | 5.38% | 7 |
|
2024
Q1 | $445M | Sell |
764,819
-13,615
| -2% | -$7.91M | 5.98% | 7 |
|
2023
Q4 | $413M | Sell |
778,434
-5,018
| -0.6% | -$2.66M | 6.23% | 5 |
|
2023
Q3 | $397M | Buy |
783,452
+29,297
| +4% | +$14.8M | 6.72% | 6 |
|
2023
Q2 | $393M | Buy |
754,155
+16,299
| +2% | +$8.5M | 6.55% | 5 |
|
2023
Q1 | $425M | Buy |
737,856
+9,747
| +1% | +$5.62M | 7.72% | 3 |
|
2022
Q4 | $401M | Buy |
728,109
+16,405
| +2% | +$9.03M | 8.06% | 1 |
|
2022
Q3 | $361M | Sell |
711,704
-5,932
| -0.8% | -$3.01M | 8.43% | 1 |
|
2022
Q2 | $390M | Buy |
717,636
+42,260
| +6% | +$23M | 8.4% | 1 |
|
2022
Q1 | $399M | Buy |
675,376
+50,729
| +8% | +$30M | 7.66% | 3 |
|
2021
Q4 | $417M | Buy |
624,647
+65,960
| +12% | +$44M | 7.83% | 2 |
|
2021
Q3 | $319M | Buy |
558,687
+60,738
| +12% | +$34.7M | 7.45% | 3 |
|
2021
Q2 | $251M | Buy |
497,949
+56,253
| +13% | +$28.4M | 6.74% | 4 |
|
2021
Q1 | $202M | Buy |
441,696
+68,002
| +18% | +$31M | 7.02% | 5 |
|
2020
Q4 | $174M | Buy |
373,694
+3,168
| +0.9% | +$1.48M | 7.59% | 4 |
|
2020
Q3 | $164M | Buy |
370,526
+98,307
| +36% | +$43.4M | 9.36% | 1 |
|
2020
Q2 | $98.6M | Buy |
272,219
+23,265
| +9% | +$8.43M | 8.6% | 3 |
|
2020
Q1 | $70.6M | Buy |
248,954
+45,181
| +22% | +$12.8M | 9.35% | 2 |
|
2019
Q4 | $66.2M | Buy |
+203,773
| New | +$66.2M | 8.97% | 3 |
|